hrcak mascot   Srce   HID

Izvorni znanstveni članak

Umbilical serum tumor necrosis factor-α and interleukin-6 in chorioamnionitis

DARKA KORDIĆ ; Department of Oncology and Nuclear Medicine, Sisters of Mercy University Hospital, Zagreb, Croatia
VESNA KOŠEC ; Department of Obstetrics and Gynecology, Sisters of Mercy University Hospital, Zagreb, Croatia
JOSIP JUKAČ ; Department of Oncology and Nuclear Medicine, Sisters of Mercy University Hospital, Zagreb, Croatia

Puni tekst: engleski, pdf (92 KB) str. 123-127 preuzimanja: 352* citiraj
APA 6th Edition
KORDIĆ, D., KOŠEC, V. i JUKAČ, J. (2009). Umbilical serum tumor necrosis factor-α and interleukin-6 in chorioamnionitis. Periodicum biologorum, 111 (1), 123-127. Preuzeto s https://hrcak.srce.hr/36029
MLA 8th Edition
KORDIĆ, DARKA, et al. "Umbilical serum tumor necrosis factor-α and interleukin-6 in chorioamnionitis." Periodicum biologorum, vol. 111, br. 1, 2009, str. 123-127. https://hrcak.srce.hr/36029. Citirano 25.09.2020.
Chicago 17th Edition
KORDIĆ, DARKA, VESNA KOŠEC i JOSIP JUKAČ. "Umbilical serum tumor necrosis factor-α and interleukin-6 in chorioamnionitis." Periodicum biologorum 111, br. 1 (2009): 123-127. https://hrcak.srce.hr/36029
Harvard
KORDIĆ, D., KOŠEC, V., i JUKAČ, J. (2009). 'Umbilical serum tumor necrosis factor-α and interleukin-6 in chorioamnionitis', Periodicum biologorum, 111(1), str. 123-127. Preuzeto s: https://hrcak.srce.hr/36029 (Datum pristupa: 25.09.2020.)
Vancouver
KORDIĆ D, KOŠEC V, JUKAČ J. Umbilical serum tumor necrosis factor-α and interleukin-6 in chorioamnionitis. Periodicum biologorum [Internet]. 2009 [pristupljeno 25.09.2020.];111(1):123-127. Dostupno na: https://hrcak.srce.hr/36029
IEEE
D. KORDIĆ, V. KOŠEC i J. JUKAČ, "Umbilical serum tumor necrosis factor-α and interleukin-6 in chorioamnionitis", Periodicum biologorum, vol.111, br. 1, str. 123-127, 2009. [Online]. Dostupno na: https://hrcak.srce.hr/36029. [Citirano: 25.09.2020.]

Sažetak
Background and Purpose: The term chorioamnionitis describes both
clinical symptoms of intrauterine infection and antenatal inflammatory
processes in the placental tissue.We studied umbilical serum tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) content in clinical chorioamnionitis with/without histological inflammation and in histological chorioamnionitis without clinical signs.

Materials and Methods: We examined amniotic and placental tissues
and umbilical cord blood samples (111) from 40 patients with clinical
chorioamnionitis and 71 without it.We stratified patients according to clinical and histological findings. Umbilical serum concentrations of TNF-α and IL-6 were determined with immunoassay. To estimate systemic inflammation in infants, we used cut off values >15 pg/mL for TNF-α and >11 pg/mL for IL-6. To analyze the results, we applied methods of nonparametric statistics.

Results: In clinical chorioamnionitis, median umbilical serum concentrations of TNF-α and IL-6 were elevated only when histological inflammation (all P<0.001) was present. In histological chorioamnionitis without clinical signs, median concentrations of TNF-a and IL-6 were also elevated (P<0.001, <0.048). The percentage of elevated cytokines was higher in chorioamnionitis with than without placental inflammation. Cytokine patterns were different in chorioamnionitis patients and controls.

Conclusion: Associated clinical and histological chorioamnionitis and
histological chorioamnionitis enhanced inflammatory cytokine concentrations and the percentage of elevated cytokine values. The contribution of clinical chorioamnionitis without placental inflammation to umbilical serum cytokine content was minor

Hrčak ID: 36029

URI
https://hrcak.srce.hr/36029

Posjeta: 547 *